[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345840-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345840-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","microrna-15a16-regulate-protein-metabolism-and-are-associated-with-clinical-outcomes-in-pancreatic-ductaladenocarcinoma","MicroRNA-15a/16 regulate protein metabolism and are associated with clinical outcomes in pancreatic ductaladenocarcinoma","","Dysregulated cellular protein metabolism is a hallmark of pancreatic ductal adenocarcinoma (PDAC), yet its regulatory mechanisms remain incompletely understood. The study examines two co-transcribed microRNAs, miR-15a/16, and their roles in protein translation, cell growth, metabolic processes, and clinical features. In cultured PDAC models, miR-15a/16 overexpression slows proliferation and reduces protein synthesis rates. Bioinformatics indicates broad pathway targeting, and patient-data analysis links higher miR-15a/16 levels to improved survival.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/microrna-15a16-regulate-protein-metabolism-and-are-associated-with-clinical-outcomes-in-pancreatic-ductaladenocarcinoma/345840/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/microrna-15a16-regulate-protein-metabolism-and-are-associated-with-clinical-outcomes-in-pancreatic-ductaladenocarcinoma/345840.png","ImageObject",300,407,{"name":42,"@type":43},"Eden","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role do miR-15a/16 play in PDAC protein metabolism?","Question",{"text":63,"@type":64},"miR-15a/16 act as regulators of protein metabolism in PDAC by influencing cellular protein translation and related metabolic processes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What effects does miR-15a/16 overexpression have in cultured PDAC models?",{"text":68,"@type":64},"Overexpressing miR-15a/16 slows cancer cell proliferation and attenuates protein synthesis rates.",{"name":70,"@type":61,"acceptedAnswer":71},"How are miR-15a/16 expression levels connected to clinical outcomes?",{"text":72,"@type":64},"Patient data show lower miR-15a/16 expression in PDAC tumors and pancreatitis compared with healthy controls, and higher miR-15a/16 in tumors is associated with improved survival.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345840,1790704157,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","DOI: 10.14814/phy2.71015  \nORIGINAL ARTICLE  \nMicroRNA-15a/16 regulate protein metabolism and are associated with clinical outcomes in pancreatic ductaladenocarcinoma  \nPatrick J. Ryan1 | Bethany C. Guerra1 | Peter P. Nghiem2 | Steven E. Riechman1 | Mariana Janini-Gomes1 | James D. Fluckey1   \n1Muscle Biology Laboratory, Department of Kinesiology and Sports Management, Texas A&M University, College Station, Texas, USA 2Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA  \nCorrespondence  \nJames D. Fluckey, Muscle Biology Laboratory, Department of Kinesiology and Sports Management, Texas A&M University, 313 GGB, 2929 Research Parkway, College Station, TX 77845, USA.  \n[Email:](Email: jfluckey@tamu.edu)[ jfluckey@tamu.edu](Email: jfluckey@tamu.edu)  \nFunding information  \nDOD | US Army | MEDCOM | Congressionally Directed Medical Research Programs (CDMRP), Grant/ Award Number: W81XWH-22-1-0988  \n1 | INTRODUCTION  \nAbstract  \nDysregulated cellular protein metabolism is a key hallmark of pancreatic ductaladenocarcinoma (PDAC) . However, much remains to be learned about how this process is regulated in cancerous cells. Here we investigated the role of two co-transcribed microRNA (miRNA) species, miR-15a/16, in regulating cellular protein translation, cell growth, metabolic processes, and clinical features in PDAC. Using cultured PDAC models, we show that overexpression of miR- 15a/16 in cancerous cells slows proliferation and attenuates protein synthesis rates. Bioinformatics analysis reveals that these miRNAs target a broad suite of pathophysiological and metabolic pathways, including numerous genes in cancerand protein-related processes. Finally, using publicly available patient data, wereport that miR-15a/16 expression is lower in PDAC tumors and in patients with pancreatitis than in healthy controls, and that high expression of miR-15a/16 in tumors is associated with improved survival in patients. Our results indicate that miR-15a/16 act as regulators of protein metabolism in PDAC, with potential clinical implications for the management of this devastating disease.  \nKEYWORDS  \ncancer, Metabolisim, miRNA, PDAC, proteostasis  \none of the deadliest tumor types in Americans, ranking third in women and fourth in men for cancer mortality  \nThe regulation of metabolism is central to cellular health. Accordingly, aberrant cellular anabolism underlies several pathophysiological conditions, from wasting diseases to diabetes to cancer. In this last domain, there is perhaps no greater demonstration of the consequences of aberrant cell growth than in pancreatic cancer. Pancreatic ductal adenocarcinoma (PDAC) is  \n(Siegel et al. , 2025) . Disturbingly, PDAC cases are on the rise in the United States (Ntukidem et al. , 2025), particularly in younger people (Abboud et al. , 2023), with no clear explanation as to what is motivating these trends. Clearly, much remains to be discovered about the molecular drivers of carcinogenesis and progression in pancreatic cancer, emphasizing the  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s). Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.  \nneed for investigation into these malignancies. In this vein, previous investigations have demonstrated that a broad program of metabolic reprogramming underlies cancerous behavior in PDAC, leading to the development of numerous targeted metabolic inhibitors (Raez et al. , 2013) . While great strides have been made in PDAC therapeutics, the ever-adaptable nature of these tumors highlights the need for continued pursuit of new insights into their basic biology.  \nReliance upon anabolic processes is one key ","cbCaidwcbvOhNfYn","https://ap.wps.com/l/cbCaidwcbvOhNfYn","pdf",2346030,11,"English","# Introduction\n## Abstract\n## Keywords","[{\"question\":\"What role do miR-15a/16 play in PDAC protein metabolism?\",\"answer\":\"miR-15a/16 act as regulators of protein metabolism in PDAC by influencing cellular protein translation and related metabolic processes.\"},{\"question\":\"What effects does miR-15a/16 overexpression have in cultured PDAC models?\",\"answer\":\"Overexpressing miR-15a/16 slows cancer cell proliferation and attenuates protein synthesis rates.\"},{\"question\":\"How are miR-15a/16 expression levels connected to clinical outcomes?\",\"answer\":\"Patient data show lower miR-15a/16 expression in PDAC tumors and pancreatitis compared with healthy controls, and higher miR-15a/16 in tumors is associated with improved survival.\"}]","MicroRNA-15a/16 regulate protein metabolism and are associated with clinical outcomes in pancreatic ductaladenocarcinoma | PDF",1790059064,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb2d41cff535b2f34b995f658312f93b.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca3e1dcd4c8f1adb2e89424a5e913113.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c9037cb5a4a4cf457c0ad04d385acbf5.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d58ec5d7bbc295619b2e4324229bb36.webp",980,1287]